Browse 100+ evidence-based profiles with community ratings, dosage guides, and safety information.
Start ExploringPublished 28 March 2026
Methylene blue (methylthioninium chloride) is one of the oldest synthetic drugs in existence - first synthesised in 1876 as a textile dye. It became the first fully synthetic drug used in medicine, treating malaria in the early 1900s. Today it is an approved pharmaceutical for methemoglobinemia (a blood disorder) and is used as a surgical dye.
In the nootropic world, methylene blue has gone viral. Podcasters, biohackers, and wellness influencers have driven a surge of interest based on its unique ability to enhance mitochondrial function in the brain. But the reality is more nuanced than the hype suggests. This guide separates what we know from what we don't.
Important: Methylene blue has real pharmacological activity and serious drug interactions. It is not a casual supplement. Read the safety section carefully. Do not combine with serotonergic medications (SSRIs, SNRIs, MAOIs, 5-HTP, St. John's Wort) - the combination can cause life-threatening serotonin syndrome.
This is the core mechanism behind the nootropic interest. Methylene blue acts as an alternative electron carrier in the mitochondrial electron transport chain (ETC). Normally, electrons pass through Complex I, III, and IV to generate ATP (cellular energy). When these complexes are damaged or inefficient - as they increasingly become with age, oxidative stress, or neurodegeneration - energy production drops.
Methylene blue can accept electrons directly from NADH and transfer them to cytochrome c, effectively bypassing dysfunctional Complex I and III. This "short-circuit" maintains ATP production even when the normal pathway is impaired. The brain, which consumes 20% of the body's energy despite being 2% of its mass, is particularly sensitive to mitochondrial efficiency.
Methylene blue follows a strict hormetic curve - low doses enhance mitochondrial function, while high doses impair it. At low concentrations (0.5-4 mg/kg in animal studies, roughly 0.5-2 mg/kg in humans), it acts as an electron donor that supports the ETC. At high concentrations, it becomes an electron thief that steals electrons from the chain, generating reactive oxygen species and actually worsening mitochondrial function.
This means more is not better. The therapeutic window is narrow, and exceeding it reverses the benefits.
At low doses, methylene blue acts as an antioxidant by cycling between its oxidised (blue) and reduced (colourless) forms - functioning as a redox cycling agent that neutralises reactive oxygen species (ROS). It has been shown to reduce lipid peroxidation and protein oxidation in brain tissue in animal models.
Methylene blue is a potent inhibitor of monoamine oxidase A (MAO-A), the enzyme that breaks down serotonin, norepinephrine, and dopamine. This is relevant for two reasons:
Methylene blue inhibits nitric oxide synthase (NOS) and guanylate cyclase. This can increase blood pressure slightly and is the mechanism behind its medical use in vasoplegic shock. For nootropic purposes, this is generally irrelevant at low doses but is worth noting for people with cardiovascular conditions.
The animal evidence is genuinely interesting:
This is where the hype outpaces the evidence:
The honest summary: the mitochondrial mechanism is well-established. The animal data is promising. But the human nootropic evidence is thin - one small study and a lot of anecdotal reports. This doesn't mean it doesn't work; it means we don't have strong proof yet.
Dosing is critical with methylene blue due to the hormetic curve. Too little does nothing; too much is counterproductive and potentially harmful.
Expect blue: Methylene blue will turn your urine blue-green and may temporarily stain your tongue and teeth. This is normal and not harmful. It can also stain clothing, surfaces, and anything it contacts.
Because methylene blue is a potent MAO-A inhibitor, the following combinations are dangerous:
The FDA has issued a specific warning about combining methylene blue with serotonergic medications. Cases of serotonin syndrome (including fatalities) have been reported even with the medical doses used for methemoglobinemia. If you take any antidepressant, methylene blue is off the table.
Quality matters enormously with methylene blue. The compound exists in multiple grades:
Always verify that your source provides a Certificate of Analysis confirming USP grade. Products marketed as supplements should state "USP grade" or "pharmaceutical grade" on the label.
If you are young, healthy, and new to nootropics, methylene blue is not where to start. Try our beginner's guide instead.
Methylene blue has a genuinely interesting mitochondrial mechanism that is well-supported by biochemistry and animal research. The human nootropic evidence is early-stage but encouraging. However, the narrow therapeutic window, serious drug interactions (especially with antidepressants), and sourcing risks make it a compound that demands respect and caution. It is not the casual brain supplement that social media sometimes portrays - it is a pharmacologically active substance with real risks alongside its real potential.
For safer mitochondrial support, consider CoQ10, PQQ, or creatine. For more on how these compare, see our CoQ10 vs PQQ guide.
At low doses (0.5-1 mg/kg) of pharmaceutical-grade product, methylene blue has a reasonable safety profile in healthy adults who are not taking serotonergic medications. However, it has a narrow therapeutic window - higher doses become harmful rather than beneficial. The most serious risk is serotonin syndrome when combined with antidepressants (SSRIs, SNRIs, MAOIs). It is also contraindicated in G6PD deficiency. It is not a beginner nootropic and requires more caution than most supplements.
The nootropic dose range is 0.5-1 mg/kg body weight, taken once daily in the morning. For a 70 kg person, this is roughly 35-70 mg. Start at the lower end (0.5 mg/kg) and only increase if well tolerated. Never exceed 2 mg/kg - higher doses reverse the benefits and become pro-oxidant. Only use pharmaceutical/USP grade methylene blue, never laboratory or industrial grade.
No. This is the single most important safety warning for methylene blue. It is a potent MAO-A inhibitor, and combining it with any serotonergic medication (SSRIs, SNRIs, MAOIs, tricyclics, 5-HTP, St. John's Wort, tramadol, or triptans) creates a serious risk of serotonin syndrome - a potentially fatal condition. The FDA has issued a specific warning about this interaction. If you take any antidepressant, methylene blue is not an option.
Methylene blue is a thiazine dye that is excreted by the kidneys. The blue colour in urine (which often appears blue-green) is simply the dye being eliminated from the body. This is completely harmless and expected at any dose. The intensity of colour roughly correlates with dose. It typically clears within 24-48 hours of your last dose.
The mitochondrial mechanism is well-established biochemistry, and animal studies consistently show memory improvements. One small human study (26 people) found that a single dose increased brain activity during memory tasks and improved recall by 7%. However, there are no large-scale human trials for cognitive enhancement. The honest answer is: the science is promising but early-stage. Many users report subjective improvements in mental clarity and energy, but robust human evidence is still limited.